Brendan C Visser Selected Research

Neoplasms (Cancer)

4/2020	Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm.
1/2020	Management of Ileal Neuroendocrine Tumors with Liver Metastases.
10/2019	Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis.
1/2018	Management of Borderline Resectable Pancreatic Cancer.
11/2016	Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.
4/2016	Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors.
1/2016	Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.
3/2015	Compliance with gastric cancer guidelines is associated with improved outcomes.
2/2015	Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform.
8/2014	Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brendan C Visser Research Topics

Disease

14	Neoplasms (Cancer) 04/2020 - 07/2011
4	Primitive Neuroectodermal Tumors (PNET) 05/2022 - 07/2012
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 01/2020
4	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2013
4	Cysts 06/2015 - 02/2012
3	Colorectal Neoplasms (Colorectal Cancer) 04/2020 - 07/2013
3	Adenocarcinoma 01/2016 - 03/2012
3	Pancreatic Cyst 06/2015 - 02/2012
3	Pancreatitis 10/2014 - 01/2013
2	Pancreatic Fistula (Pancreatic Fistulas) 03/2024 - 02/2014
2	Acute Necrotizing Pancreatitis 02/2024 - 10/2014
2	Fistula 11/2018 - 02/2014
2	Sarcoma (Soft Tissue Sarcoma) 10/2015 - 01/2014
1	Hemorrhage 10/2023
1	Abscess 10/2023
1	Infarction (Infarctions) 10/2023
1	Pain (Aches) 05/2022
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2022
1	Multiple Endocrine Neoplasia Type 1 01/2022
1	Polycystic liver disease 01/2021
1	Carcinoid Tumor (Carcinoid) 12/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Neuroendocrine Carcinoma 01/2020
1	Lung Diseases (Lung Disease) 10/2019
1	Idiopathic Pulmonary Fibrosis 10/2019
1	Cutaneous Fistula 11/2018
1	Margins of Excision 01/2018
1	Death (Near-Death Experience) 01/2017
1	Chronic Pancreatitis 01/2017
1	Lymphoma (Lymphomas) 11/2016
1	Residual Neoplasm 11/2016
1	Heart Arrest (Cardiac Arrest) 01/2016
1	Heart Failure 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Heart Diseases (Heart Disease) 01/2016
1	Myocardial Infarction 01/2016
1	Necrosis 11/2015
1	Stomach Neoplasms (Stomach Cancer) 03/2015
1	Wounds and Injuries (Trauma) 10/2014
1	Gallstones (Gallstone) 09/2013
1	Serous Cystadenoma 08/2013
1	Circulating Neoplastic Cells 07/2013
1	Hepatic Infarction 09/2012
1	Hepatocellular Carcinoma (Hepatoma) 07/2011
1	Cystadenoma 07/2011
1	Lentigo (Lentiginosis) 03/2010

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 08/2013 - 02/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 11/2015
2	Cell-Free Nucleic AcidsIBA 11/2016 - 07/2013
2	Circulating Tumor DNAIBA 11/2016 - 02/2015
2	Carcinoembryonic AntigenIBA 06/2015 - 02/2015
2	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 08/2013
1	Atrial Natriuretic Factor (ANF)IBA 02/2024
1	BilirubinIBA 05/2022
1	Yttrium-90IBA 04/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	OMS 2017IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	IntegrinsIBA 10/2019
1	Cystine (L-Cystine)IBA 10/2019
1	Cystine-Knot MiniproteinsIBA 10/2019
1	Biological FactorsIBA 11/2016
1	Immunoglobulins (Immunoglobulin)IBA 11/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2016
1	AntigensIBA 04/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Metformin (Glucophage)FDA LinkGeneric 01/2016
1	Reagent StripsIBA 06/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	Amylases FDA Link 02/2014
1	KynurenineIBA 08/2013
1	AmphiregulinIBA 02/2012

Therapy/Procedure

7	Therapeutics 04/2020 - 07/2003
4	Hepatectomy 01/2021 - 07/2011
4	Pancreaticoduodenectomy 01/2017 - 09/2012
3	Pancreatectomy 01/2022 - 07/2012
2	Length of Stay 03/2024 - 05/2022
2	Radiotherapy 04/2020 - 11/2014
2	Neoadjuvant Therapy 01/2018 - 07/2003
2	Minimally Invasive Surgical Procedures 08/2014 - 06/2012
2	Cholecystectomy 09/2013 - 01/2013
1	Conversion to Open Surgery 03/2024
1	Splenectomy 10/2023
1	Thrombectomy 05/2022
1	Ligation 12/2020
1	Combination Drug Therapy (Combination Chemotherapy) 01/2020
1	Continuity of Patient Care 01/2017
1	Cardiopulmonary Resuscitation (CPR) 01/2016
1	Percutaneous Coronary Intervention 01/2016
1	Enteral Nutrition (Feeding, Tube) 11/2015
1	Contraindications 10/2015
1	Debridement 10/2014
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2014
1	Operative Surgical Procedures 09/2012
1	Conformal Radiotherapy 03/2012
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2012
1	Patient Discharge 07/2011